Homocysteine and Atherothrombosis
George N. Welch, Joseph Loscalzo
New England Journal of Medicine · 1998 · 1,998 citations
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Welch, G. N., & Loscalzo, J. (1998). Homocysteine and atherothrombosis. New England Journal of Medicine, 338(15), 1042–1050. https://doi.org/10.1056/nejm199804093381507
In text: (Welch & Loscalzo, 1998)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
In 1969, McCully made the clinical observation linking elevated plasma homocyst(e)ine concentrations with vascular disease.1 He reported autopsy evidence of extensive arterial thrombosis and atherosclerosis in two children with elevated plasma homocyst(e)ine concentrations and homocystinuria. On the basis of this observation, he proposed that elevated plasma homocyst(e)ine (hyperhomocyst(e)inemia) can cause atherosclerotic vascular disease. The term “homocyst(e)ine” is used to define the combined pool of homocysteine, homocystine, mixed disulfides involving homocysteine, and homocysteine thiolactone found in the plasma of patients with hyperhomocyst(e)inemia.Subsequent investigations have confirmed McCully's hypothesis, and it has recently become clear that hyperhomocyst(e)inemia is an independent risk factor . . .
Related papers
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease1995
- Tietz Textbook of Clinical Chemistry1999
- Homocysteine and Cardiovascular Disease1998
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease1991
- Homocysteine and Risk of Ischemic Heart Disease and Stroke2002
Metadata from OpenAlex (CC0). Citations are generated from the published record.